• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康状态效用值:一个用于研究想象与现实之间差距的框架。

Health state utilities: a framework for studying the gap between the imagined and the real.

作者信息

Stiggelbout Anne M, de Vogel-Voogt Elsbeth

机构信息

Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Value Health. 2008 Jan-Feb;11(1):76-87. doi: 10.1111/j.1524-4733.2007.00216.x.

DOI:10.1111/j.1524-4733.2007.00216.x
PMID:18237362
Abstract

OBJECTIVES

Health state utilities play an important role in decision analysis and cost-utility analysis. The question whose utilities to use at various levels of health-care decision-making has been subject of considerable debate. The observation that patients often value their own health, but also other health states, higher than members of the general public raises the question what underlies such differences? Is it an artifact of the valuation methods? Is it adaptation versus poor anticipated adaptation? This article describes a framework for the understanding and study of potential mechanisms that play a role in health state valuation. It aims at connecting research from within different fields so that cross-fertilization of ideas may occur.

METHODS

The framework is based on stimulus response models from social judgment theory. For each phase, from stimulus, through information interpretation and integration, to judgment, and, finally, to response, we provide evidence of factors and processes that may lead to different utilities in patients and healthy subjects.

RESULTS

Examples of factors and processes described are the lack of scope of scenarios in the stimulus phase, and appraisal processes and framing effects in the information interpretation phase. Factors that play a role in the judgment phase are, for example, heuristics and biases, adaptation, and comparison processes. Some mechanisms related to the response phase are end aversion bias, probability distortion, and noncompensatory decision-making.

CONCLUSIONS

The framework serves to explain many of the differences in valuations between respondent groups. We discuss some of the findings as they relate to the field of response shift research. We propose issues for discussion in the field, and suggestions for improvement of the process of utility assessment.

摘要

目的

健康状态效用值在决策分析和成本效用分析中发挥着重要作用。在不同层次的医疗保健决策中使用谁的效用值这一问题一直是大量辩论的主题。患者通常比普通公众更看重自身健康状态以及其他健康状态,这一观察结果引发了一个问题,即这种差异的根源是什么?是评估方法的人为因素?是适应与预期适应不良?本文描述了一个用于理解和研究在健康状态评估中起作用的潜在机制的框架。其目的是将不同领域的研究联系起来,以便可能产生思想的交叉融合。

方法

该框架基于社会判断理论中的刺激反应模型。对于从刺激到信息解读与整合、再到判断,最后到反应的每个阶段,我们都提供了可能导致患者和健康受试者产生不同效用值的因素和过程的证据。

结果

所描述的因素和过程的例子包括刺激阶段情景范围的不足,以及信息解读阶段的评估过程和框架效应。在判断阶段起作用的因素例如启发法和偏差、适应以及比较过程。与反应阶段相关的一些机制是终点厌恶偏差、概率扭曲和非补偿性决策。

结论

该框架有助于解释应答组之间评估中的许多差异。我们讨论了一些与反应转移研究领域相关的发现。我们提出了该领域有待讨论的问题,以及改进效用评估过程的建议。

相似文献

1
Health state utilities: a framework for studying the gap between the imagined and the real.健康状态效用值:一个用于研究想象与现实之间差距的框架。
Value Health. 2008 Jan-Feb;11(1):76-87. doi: 10.1111/j.1524-4733.2007.00216.x.
2
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
3
Application of cost-effectiveness analysis to multiple products: a practical guide.成本效益分析在多种产品中的应用:实用指南。
Am J Manag Care. 2002 Mar;8(3):211-8.
4
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
5
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
6
Health outcomes in economic evaluation: who should value health?健康结果在经济评价中的应用:谁应该评估健康?
Br Med Bull. 2011;97:197-210. doi: 10.1093/bmb/ldr001. Epub 2011 Jan 31.
7
The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.矫正方法:基于前景理论的 QALY 测量新进展对政策的启示。
Value Health. 2019 Jul;22(7):816-821. doi: 10.1016/j.jval.2019.01.013. Epub 2019 May 17.
8
Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.应答量表使用中的个体差异决定了对假设健康状态的估值:一项实证研究。
BMC Health Serv Res. 2007 Apr 27;7:62. doi: 10.1186/1472-6963-7-62.
9
[Valuation of health-related quality of life and utilities in health economics].[健康经济学中与健康相关的生活质量评估及效用评估]
Z Evid Fortbild Qual Gesundhwes. 2014;108(2-3):120-5. doi: 10.1016/j.zefq.2014.02.004. Epub 2014 Apr 2.
10
Preferences for health outcomes and cost-utility analysis.对健康结果的偏好与成本效用分析。
Am J Manag Care. 1997 May;3 Suppl:S8-20.

引用本文的文献

1
Do generic population utility scores accurately represent real-world experienced health?通用人群效用评分能否准确代表现实世界中经历的健康状况?
Qual Life Res. 2025 Sep 10. doi: 10.1007/s11136-025-04060-4.
2
Differences in health state valuation for small, low-risk thyroid cancer between general population and cancer survivors: a cross-sectional analysis.普通人群与癌症幸存者对小型、低风险甲状腺癌健康状态评估的差异:一项横断面分析。
Qual Life Res. 2025 Aug 23. doi: 10.1007/s11136-025-04033-7.
3
Surgical prioritization based on decision model outcomes is not sensitive to differences between the health-related quality of life values estimates of physicians and citizens.
基于决策模型结果的手术优先级排序对医生和公民的健康相关生活质量价值评估之间的差异不敏感。
Qual Life Res. 2024 Feb;33(2):529-539. doi: 10.1007/s11136-023-03544-5. Epub 2023 Nov 8.
4
Decision aids to assist patients and professionals in choosing the right treatment for kidney failure.帮助患者和专业人员选择合适的肾衰竭治疗方法的决策辅助工具。
Clin Kidney J. 2023 Sep 13;16(Suppl 1):i20-i38. doi: 10.1093/ckj/sfad172. eCollection 2023 Sep.
5
Factors Affecting Health-Related Quality of Life in Patients With Metastatic Breast Cancer.影响转移性乳腺癌患者健康相关生活质量的因素
J Breast Cancer. 2023 Oct;26(5):436-445. doi: 10.4048/jbc.2023.26.e29. Epub 2023 Jul 11.
6
Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation.父母对接受造血干细胞移植的镰状细胞病患儿和青少年的不孕风险及生育力保存选择的看法。
Pediatr Blood Cancer. 2023 Jul;70(7):e30276. doi: 10.1002/pbc.30276. Epub 2023 Apr 13.
7
Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?使用离散选择实验评估EQ-5D-Y-3L健康状态:成人和青少年的偏好是否不同?
Med Decis Making. 2021 Jul;41(5):584-596. doi: 10.1177/0272989X21999607. Epub 2021 Mar 18.
8
Implications of response shift for micro-, meso-, and macro-level healthcare decision-making using results of patient-reported outcome measures.使用患者报告的结果测量结果对微观、中观和宏观医疗保健决策进行反应转移的影响。
Qual Life Res. 2021 Dec;30(12):3343-3357. doi: 10.1007/s11136-021-02766-9. Epub 2021 Mar 2.
9
A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' Experience.乳腺癌效用权重的Meta回归分析:患者体验的影响力
Int J Environ Res Public Health. 2020 Dec 15;17(24):9412. doi: 10.3390/ijerph17249412.
10
Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease.原发性照料者在造血干细胞移植和镰状细胞病基因治疗中的决策。
Pediatr Blood Cancer. 2021 Jan;68(1):e28749. doi: 10.1002/pbc.28749. Epub 2020 Oct 8.